Procter & Gamble stock trades at 23.88 times earnings as sales grow 3 percent

Published on 10/27/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cash flow reached USD 19.6 billion in fiscal 2026. Procter & Gamble stock costs EUR 142.33 on October 27, 2026, down 0.45 percent versus Xetra close.

Fiscal sales and cash flow

Fiscal 2026 net sales reached USD 87.0 billion, up 3.00 percent.
Operating cash flow totaled USD 19.6 billion in fiscal 2026.
Procter & Gamble stock costs EUR 142.33 at Lang & Schwarz on October 27, 2026 at 5:18 p.m. CEST, down 0.45 percent versus the Xetra close of October 26, 2026.
The next earnings release is scheduled for January 20, 2027.

Procter & Gamble, US7427181091, Illustration mit AI erstellt.

Procter & Gamble reported fiscal 2026 net sales of USD 87.0 billion, up 3.00 percent, while its price-to-earnings ratio stood at 23.88 on October 27, 2026. Procter & Gamble also reported USD 19.6 billion in operating cash flow for fiscal 2026. At Lang & Schwarz, the stock was trading at EUR 142.33 on October 27, 2026 at 5:18 p.m. CEST, down 0.45 percent versus the Xetra close of October 26, 2026 at EUR 142.98.

Sales growth meets cash generation

The fiscal-year figures show a modest top-line advance alongside substantial cash generation. Net sales increased from USD 84.3 billion in fiscal 2025 to USD 87.0 billion in fiscal 2026, a rise of 3.26 percent. Operating cash flow climbed from USD 17.8 billion to USD 19.6 billion over the same periods, an increase of 9.76 percent.

That combination gives the latest annual picture more depth than the sales figure alone. Diluted earnings per share rose from USD 6.51 in fiscal 2025 to USD 6.62 in fiscal 2026, while the operating margin eased from 24.00 percent to 23.00 percent.

Stock position on October 27

The NYSE quote was USD 158.51 at 12:28 p.m. EDT on October 27, 2026, with a market capitalization of USD 367.4 billion and a price-to-earnings ratio of 23.88. The 52-week range was USD 137.62 to USD 167.25 on the same market snapshot, placing the price USD 8.74 below the high and USD 20.89 above the low.

In euros, the Lang & Schwarz quotation was below the previous Xetra close by EUR 0.65. The move stayed below the 1.00 percent threshold that would support a directional headline, so the annual figures remain the stronger point of reference for the stock report.

When is the next report?

Zacks lists January 20, 2027 as the next expected earnings release date. Its latest calendar also records fiscal first-quarter earnings per share of USD 2.00 against a USD 1.89 consensus estimate on October 22, 2026, a positive difference of 5.82 percent.

For the stock, the important balance is clear in the dated figures: fiscal 2026 sales rose 3.00 percent, operating cash flow rose 9.76 percent, and the operating margin declined by 1.00 percentage point. The next reporting date will provide the next test of that balance.

Market value and upcoming date

Procter & Gamble combines a USD 367.4 billion market capitalization with a 23.88 price-to-earnings ratio and a 52-week high of USD 167.25. The next scheduled earnings date is January 20, 2027.

The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.